Citigroup
GNCA

Citigroup’s Genocea Biosciences, Inc. GNCA Stock Holding History

Citigroup’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-250
Closed -$1K – 6575
2021
Q2 		$1K Hold
250
– – ﹤0.01% 6087
2021
Q1 		$1K Hold
250
– – ﹤0.01% 6144
2020
Q4 		$1K Sell
250
-1,250
-83% -$2.85K ﹤0.01% 7322
2020
Q3 		$3K Hold
1,500
– – ﹤0.01% 7266
2020
Q2 		$3K Hold
1,500
– – ﹤0.01% 7377
2020
Q1 		$3K Hold
1,500
– – ﹤0.01% 7404
2019
Q4 		$3K Hold
1,500
– – ﹤0.01% 7524
2019
Q3 		$4K Hold
1,500
– – ﹤0.01% 7430
2019
Q2 		$6K Sell
1,500
-125
-8% -$652 ﹤0.01% 7463
2019
Q1 		$8K Hold
1,625
– – ﹤0.01% 7325
2018
Q4 		$4K Hold
1,625
– – ﹤0.01% 7431
2018
Q3 		$10K Hold
1,625
– – ﹤0.01% 7370
2018
Q2 		$11K Sell
1,625
-1,325
-45% -$9.91K ﹤0.01% 7171
2018
Q1 		$25K Buy
2,950
+938
+47% +$7.79K ﹤0.01% 6639
2017
Q4 		$18K Buy
2,012
+126
+7% +$1.27K ﹤0.01% 6797
2017
Q3 		$22K Buy
1,886
+127
+7% +$4.82K ﹤0.01% 6418
2017
Q2 		$73K Buy
1,759
+1,259
+252% +$60.6K ﹤0.01% 5559
2017
Q1 		$24K Hold
500
– – ﹤0.01% 6167
2016
Q4 		$16K Hold
500
– – ﹤0.01% 6616
2016
Q3 		$20K Buy
500
+187
+60% +$7.34K ﹤0.01% 6225
2016
Q2 		$10K Sell
313
-2,944
-90% -$108K ﹤0.01% 6570
2016
Q1 		$202K Buy
3,257
+2,155
+196% +$68.4K ﹤0.01% 5086
2015
Q4 		$46K Sell
1,102
-285
-21% -$13.6K ﹤0.01% 6009
2015
Q3 		$76K Sell
1,387
-180
-11% -$17.9K ﹤0.01% 5158
2015
Q2 		$172K Buy
1,567
+478
+44% +$44.4K ﹤0.01% 4553
2015
Q1 		$104K Buy
1,089
+1,005
+1,196% +$70.9K ﹤0.01% 5006
2014
Q4 		$5K Buy
84
+67
+394% +$4.58K ﹤0.01% 6693
2014
Q3 		$1K Buy
17
+7
+70% +$767 ﹤0.01% 6979
2014
Q2 		$2K Buy
10
+7
+233% +$1.06K ﹤0.01% 6815
2014
Q1 		$0 Buy
+3
New +$368 ﹤0.01% 7307

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup's GNCA Position: Q3 2021 in Review

Citigroup sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2021, closing a stake of 250 shares — an estimated $1K sold.

Citigroup first reported a position in GNCA in Q1 2014 and held it in 30 quarters. The position peaked at $202K in Q1 2016. 40 funds tracked by Wall St. Rank hold GNCA as of Q3 2021.

  • Citigroup reported no remaining Genocea Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 250 Genocea Biosciences, Inc. shares in Q3 2021, an estimated $1K.
  • Citigroup first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 30 quarters.
  • Citigroup's Genocea Biosciences, Inc. position peaked at $202K in Q1 2016.
  • 40 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.